Highly sensitive COVID-19 sensor for high throughput antibody screening
IBIS Technologies evaluated our recently launched G-type SARS-CoV-2 S1 protein SensEye and showed the value of this research and diagnostics tool in high throughput antibody screening of COVID-19 donor sera by SPR. A serum panel of 15 Covid-19 positive donors was assayed resulting in a 100% correlation between ELISA and SPR results for IgG antibodies whereas for IgM, the SPR-assay showed to be more sensitive than ELISA .
Find out more and read the IBIS Technologies white paper